Social Capital Suvretta Holdings Corp. I (DNAA): Price and Financial Metrics
DNAA Price/Volume Stats
| Current price | $14.07 | 52-week high | $17.44 |
| Prev. close | $9.57 | 52-week low | $9.07 |
| Day low | $9.48 | Volume | 4,628,400 |
| Day high | $17.44 | Avg. volume | 182,488 |
| 50-day MA | $9.98 | Dividend yield | N/A |
| 200-day MA | $9.91 | Market Cap | 360.75M |
DNAA Stock Price Chart Interactive Chart >
Social Capital Suvretta Holdings Corp. I (DNAA) Company Bio
Social Capital Suvretta Holdings Corp. I intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on a target business operating in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.
Latest DNAA News From Around the Web
Below are the latest news stories about SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I that investors may wish to consider to help them evaluate DNAA as an investment opportunity.
Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with RobloxBOSTON & SANTA MONICA, Calif., May 26, 2022--Akili Interactive ("Akili"), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, and Roblox (NYSE: RBLX), a global platform bringing millions of people together through shared experiences, today announced a collaboration that connects patients' medical treatments to their favorite virtual worlds. |
Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day SummitBOSTON, April 04, 2022--Akili Interactive ("Akili" or the "Company"), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced that management will present at Chardan’s Prescription Digital Therapeutics Half-Day Summit on Monday, April 11, 2022 at 2:00 p.m. E.T. |
Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product OfficerBOSTON, March 17, 2022--Akili Appoints Game Industry Veteran Jon David as Chief Product Officer |
Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital TherapeuticsBOSTON, March 10, 2022--Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital Therapeutics |
Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022BOSTON, March 08, 2022--Akili has been named to Fast Company's Annual list of the World's 50 Most Innovative Companies |
DNAA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...